A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C. diff) guided by the principles of ...

Please provide your email address to receive an email when new articles are posted on . Lewis and colleagues tested the three EHR-based interventions at three hospitals. The first intervention, ...

Please provide your email address to receive an email when new articles are posted on . Two-step testing was associated with a decrease in hospital-onset C. difficile infection. Similar decreases were ...

Most laboratories have begun using polymerase chain reaction assays, or the PCR technique, as opposed to enzyme-linked immunosorbent assay detection, also known as ELISA testing, to diagnose ...

An EMR-based alert helped reduce unnecessary orders for testing for Clostridioides difficile infection in hospitals, according to a study published in Infection Control & Hospital Epidemiology.

After the first year of interventions at Emory Saint Joseph's Hospital, there was a 63% decrease in hospital-onset C. diff cases as compared to the two years prior. Through a series of interventions ...

Clostridium difficile infection is one of the most common healthcare-associated infections in adults in the United States. Older Americans are especially vulnerable to CDI, 2 and this infection has ...

Current hospital tests for the bacterium Clostridium difficile (C. difficile) are not accurate enough and a new two-stage process should be introduced to avoid misdiagnosis and its consequences. These ...

SALT LAKE CITY--(BUSINESS WIRE)-- Great Basin Corporation, a privately held life sciences company developing sample-to-result molecular diagnostic solutions, today announced it has submitted a 510(k) ...

Dogs have previously shown promise in sniffing out bacterial infections, but a new Canadian study is walking those assertions back. Investigators with the Michael Garron Hospital were recently the ...

Great Basin Corp. has announced it has received FDA 510(k) clearance for its molecular diagnostic test for Clostridium difficile, according to a news release (pdf). “Workflow matters, especially when ...

Tests for the Clostridium difficile infection are missing up to 20% of cases and falsely diagnosing thousands of others, researchers have said. A study by St George's, University of London, and St ...